Leukemia (ALL, AML, CLL, CML)

 Originating in the bone marrow, leukaemia is a kind of cancer that influences blood and causes the aberrant white blood cells to proliferate uncontrollably. Based on the kind of blood cell involved (lymphoid or myeloid) and the speed of disease progression—acute or chronic—there are four primary forms of leukaemia. 

Most often affecting youngsters, acute lymphoblastic leukaemia (ALL) advances quickly and calls for prompt treatment. Usually found during regular blood testing, slow-growing chronic lymphocytic leukaemia (CLL) mostly affects older individuals. Commonly linked to the Philadelphia chromosome mutation, chronic myeloid leukaemia (CML) is typified by an overpopulation of myeloid cells.
Among the symptoms might be weight loss, fever, regular infections, unexplained bruising or bleeding, and tiredness. Usually, diagnosis calls for blood tests, bone marrow biopsies, and genetic analysis. 
Type of treatment available varies and could include immunotherapy, targeted therapy, chemotherapy, and even bone marrow transplantation. Particularly with chronic forms of leukaemia, early identification and treatment advances have dramatically raised survival rates.